Interferon-gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human Langerhans cells
- 1 June 1997
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 136 (6) , 831-837
- https://doi.org/10.1111/j.1365-2133.1997.tb03921.x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Interferon‐γ and interleukin‐10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7‐1) expressionEuropean Journal of Immunology, 1996
- Functional CD86 (B7-2/B70) on Cultured Human Langerhans CellsJournal of Investigative Dermatology, 1996
- Low‐dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co‐stimulatory molecules on human Langerhans cellsEuropean Journal of Immunology, 1995
- B7‐1 expression of Langerhans cells is up‐regulated by proinflammatory cytokines, and is down‐regulated by interferon‐γ or by interleukin‐10European Journal of Immunology, 1995
- B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells.The Journal of Experimental Medicine, 1994
- Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytesImmunology Today, 1994
- Expression of the B7/BB1 Activation Antigen and its Ligand CD28 in T-Cell-Mediated Skin DiseasesJournal of Investigative Dermatology, 1994
- Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.The Journal of Experimental Medicine, 1994
- B70 antigen is a second ligand for CTLA-4 and CD28Nature, 1993
- The Mixed Epidermal Cell-Lymphocyte Reaction. II. Epidermal Langerhans Cells Are Responsible for the Enhanced Allogeneic Lymphocyte-Stimulating Capacity of Normal Human Epidermal Cell SuspensionsJournal of Investigative Dermatology, 1985